SBL
ABMD

Sargent Bickham Lagudis’s Abiomed Inc ABMD Stock Holding History

Sargent Bickham Lagudis’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-150
Closed -$26K – 948
2019
Q4 		$26K Hold
150
– – ﹤0.01% 489
2019
Q3 		$27K Hold
150
– – ﹤0.01% 429
2019
Q2 		$39K Hold
150
– – ﹤0.01% 401
2019
Q1 		$43K Buy
+150
New +$49.9K 0.01% 410

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sargent Bickham Lagudis's ABMD Position: Q1 2020 in Review

Sargent Bickham Lagudis sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 150 shares — an estimated $26K sold.

Sargent Bickham Lagudis first reported a position in ABMD in Q1 2019 and held it in 4 quarters. The position peaked at $43K in Q1 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Sargent Bickham Lagudis reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 150 Abiomed Inc shares in Q1 2020, an estimated $26K.
  • Sargent Bickham Lagudis first reported a position in Abiomed Inc in Q1 2019 and held it in 4 quarters.
  • Sargent Bickham Lagudis's Abiomed Inc position peaked at $43K in Q1 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2020, filed 7 Sep 2021.